Lixte Biotechnology (LIXT) Q4 2023 Earnings

19MarConfirmed
Q4 2022
Q2 2023
Q3 2023
Q4 2023
-1
-0.7
-0.4
-0.1

Details

Expected EPS
N/A
Actual EPS
-0.41
Surprise EPS
-0.41
Surprise Percent
+∞%

Description

Lixte Biotechnology (LIXT) has reported earnings of -0.41 per share for Q4 2023.

0 Comments

Share your thoughts